Market Overview:
Lung cancer is a type of cancer that starts in the lungs. The most common symptoms are coughing, chest pain, and shortness of breath. Lung cancer is the leading cause of death from cancer worldwide. In 2018, it is estimated that there will be 1.8 million new cases of lung cancer and 1.6 million deaths from lung cancer globally1 .The global lung cancer market was valued at USD XX billion in 2017 and is expected to reach USD XX billion by 2030, growing at a CAGR of XX% during the forecast period (2018-2030)2 . The global lung Cancer market can be segmented on the basis of type into surgery, chemotherapy, radiotherapy, photodynamic therapy (PDT), laser therapy3 .On the basis on application ,the market can be segmented into hospital & clinics ,cancer research centers and others4 .
Product Definition:
Lung cancer is a type of cancer that starts in the lungs. It is a leading cause of death from cancer in both men and women.
Surgery:
Surgery is the procedure performed by the doctor or any other qualified person with the help of surgical tools and instruments. The surgery can be classified into open surgery, laparoscopic surgery, thoracoscopic (thoracotomy) or closed (vegetative) surgery.
Chemotherapy:
Chemotherapy is the use of drugs or chemical substances to treat cancer. Chemotherapy includes a group of medical services used to treat cancer. The most common types of chemotherapies include alkylating agents, cytotoxic agents, plant derivatives, and antimetabolites.
Global chemotherapy.
The global chemotherapy.
Application Insights:
The others segment held the largest share of the global market in 2017. This segment includes non-small cell lung cancer and smoking cessation clinics. The application of laser therapy for treating this condition is expected to witness a high growth rate over the forecast period owing to increasing prevalence rates coupled with rising awareness about early treatment. In addition, several research initiatives are underway that focus on developing effective therapies for advanced lung cancer patients who have failed conventional treatments or cannot undergo surgery due to their medical conditions.
In North America, hospital & clinics dominated the application segment with a revenue share of around 60% in 2017 owing to availability of various treatment options at affordable prices and convenient locations across major cities such as New York City, Los Angeles County and Miami-Dade County.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, availability of novel therapies, high adoption rate for innovative treatment options and well-established healthcare infrastructure. Moreover, increasing government funding for research & development activities is also expected to drive growth during the forecast period. Asia Pacific is estimated to witness lucrative growth over the forecast period owing to rising disposable income levels and improving economic conditions in emerging countries such as China and India.
Growth Factors:
- Increasing incidence of lung cancer due to changing lifestyle and environmental factors.
- Growing awareness about the early detection and treatment of lung cancer through various campaigns and initiatives by government and non-government organizations.
- Rising demand for better quality of life among patients with advanced stage lung cancer, which is driving the adoption of novel therapies such as immunotherapy drugs.
- Increasing number of clinical trials for new drug development in the field of lung cancer therapy is expected to fuel market growth during forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Lung Cancer Market Research Report
By Type
Surgery, Chemotherapy, Radiotherapy, Photodynamic Therapy, Laser Therapy
By Application
Hospital & Clinics, Cancer Research Centers, Others
By Companies
Roche, Novartis, Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly And Company, Sanof
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Lung Cancer Market Report Segments:
The global Lung Cancer market is segmented on the basis of:
Types
Surgery, Chemotherapy, Radiotherapy, Photodynamic Therapy, Laser Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinics, Cancer Research Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Novartis
- Pfizer
- Merck
- Bristol-Myers Squibb
- Eli Lilly And Company
- Sanof
Highlights of The Lung Cancer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Chemotherapy
- Radiotherapy
- Photodynamic Therapy
- Laser Therapy
- By Application:
- Hospital & Clinics
- Cancer Research Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lung Cancer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lung cancer is a type of cancer that begins in the lungs. It can be caused by smoking, exposure to asbestos, or other factors. Lung cancer often spreads to other parts of the body. Treatment depends on the stage and location of the tumor.
Some of the major companies in the lung cancer market are Roche, Novartis, Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly And Company, Sanof.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lung Cancer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lung Cancer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lung Cancer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lung Cancer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lung Cancer Market Size & Forecast, 2018-2028
4.5.1 Lung Cancer Market Size and Y-o-Y Growth
4.5.2 Lung Cancer Market Absolute $ Opportunity
Chapter 5 Global Lung Cancer Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Lung Cancer Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Chemotherapy
5.2.3 Radiotherapy
5.2.4 Photodynamic Therapy
5.2.5 Laser Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Lung Cancer Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Lung Cancer Market Size Forecast by Applications
6.2.1 Hospital & Clinics
6.2.2 Cancer Research Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lung Cancer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lung Cancer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Lung Cancer Analysis and Forecast
9.1 Introduction
9.2 North America Lung Cancer Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Lung Cancer Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Chemotherapy
9.6.3 Radiotherapy
9.6.4 Photodynamic Therapy
9.6.5 Laser Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Lung Cancer Market Size Forecast by Applications
9.10.1 Hospital & Clinics
9.10.2 Cancer Research Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Lung Cancer Analysis and Forecast
10.1 Introduction
10.2 Europe Lung Cancer Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Lung Cancer Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Chemotherapy
10.6.3 Radiotherapy
10.6.4 Photodynamic Therapy
10.6.5 Laser Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Lung Cancer Market Size Forecast by Applications
10.10.1 Hospital & Clinics
10.10.2 Cancer Research Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Lung Cancer Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Lung Cancer Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Lung Cancer Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Chemotherapy
11.6.3 Radiotherapy
11.6.4 Photodynamic Therapy
11.6.5 Laser Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Lung Cancer Market Size Forecast by Applications
11.10.1 Hospital & Clinics
11.10.2 Cancer Research Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Lung Cancer Analysis and Forecast
12.1 Introduction
12.2 Latin America Lung Cancer Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Lung Cancer Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Chemotherapy
12.6.3 Radiotherapy
12.6.4 Photodynamic Therapy
12.6.5 Laser Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Lung Cancer Market Size Forecast by Applications
12.10.1 Hospital & Clinics
12.10.2 Cancer Research Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Lung Cancer Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Lung Cancer Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Lung Cancer Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Chemotherapy
13.6.3 Radiotherapy
13.6.4 Photodynamic Therapy
13.6.5 Laser Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Lung Cancer Market Size Forecast by Applications
13.10.1 Hospital & Clinics
13.10.2 Cancer Research Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lung Cancer Market: Competitive Dashboard
14.2 Global Lung Cancer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Novartis
14.3.3 Pfizer
14.3.4 Merck
14.3.5 Bristol-Myers Squibb
14.3.6 Eli Lilly And Company
14.3.7 Sanof
